Australien - engelska - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - dextromethorphan hydrobromide monohydrate, quantity: 10.5 mg - pastille - excipient ingredients: menthol; acacia; saccharin sodium; white beeswax; betadex; quinoline yellow; sodium cyclamate; light liquid paraffin; maltitol solution; citric acid; flavour - bisolvon dry pastilles are used for the symptomatic treatment of dry, irritant, unproductive coughs and helps soothe the throat.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - dextromethorphan hydrobromide monohydrate, quantity: 2 mg/ml - oral liquid - excipient ingredients: propylene glycol; purified water; maltitol solution; methyl hydroxybenzoate; saccharin sodium; flavour; fragrance (perfume) - cough suppressant

USA - engelska - NLM (National Library of Medicine)

proficient rx lp - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see precautions, drug interactions ). promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. according to the who expert committee on drug dependence, dextromethorphan could produce very slight psychic dependence but no physical dependence.

USA - engelska - NLM (National Library of Medicine)

atlantic biologicals corp. - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see ). precautions, drug interactions promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. according to the who expert committee on drug dependence, dextromethorphan could produce very slight psychic dependence but no physical dependence.

USA - engelska - NLM (National Library of Medicine)

rebel distributors corp - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see precautions, drug interactions ). promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. according to the who expert committee on drug dependence, dextromethorphan could produce very slight psychic dependence but no physical dependence.

USA - engelska - NLM (National Library of Medicine)

morton grove pharmaceuticals, inc. - dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494) - dextromethorphan hydrobromide 15 mg in 5 ml - promethazine hydrochloride and dextromethorphan hydrobromide syrup is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (maoi) (see precautions, drug interactions ). promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. according to the who expert committee on drug dependence, dextromethorphan could produce very slight psychic dependence but no physical dependence.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

johnson & johnson (new zealand) limited - dextromethorphan hydrobromide monohydrate 10mg equivalent to 7.3 mg dextromethorphan;  ; paracetamol 500mg; phenylephrine hydrochloride 5mg equivalent to 4.1 mg phenylephrine;  ; chlorphenamine maleate 2mg; dextromethorphan hydrobromide monohydrate 10mg equivalent to 7.3 mg dextromethorphan; paracetamol 500mg - combination capsule - active: dextromethorphan hydrobromide monohydrate 10mg equivalent to 7.3 mg dextromethorphan   paracetamol 500mg phenylephrine hydrochloride 5mg equivalent to 4.1 mg phenylephrine   excipient: allura red ac   brilliant blue fcf   colloidal silicon dioxide opacode black gelatin   silicified microcrystalline cellulose (49mg microcrystalline cellulose bp, 1mg silicon dioxide bp) magnesium stearate purified talc quinoline yellow   sodium laurilsulfate titanium dioxide   active: chlorphenamine maleate 2mg dextromethorphan hydrobromide monohydrate 10mg equivalent to 7.3 mg dextromethorphan paracetamol 500mg excipient: allura red ac brilliant blue fcf colloidal silicon dioxide opacode black gelatin   lactose monohydrate magnesium stearate purified talc sodium laurilsulfate titanium dioxide  

Australien - engelska - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - dextromethorphan hydrobromide monohydrate, quantity: 10 mg; paracetamol, quantity: 500 mg; phenylephrine hydrochloride, quantity: 5 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; microcrystalline cellulose; hypromellose; stearic acid; silicon dioxide; titanium dioxide; quinoline yellow; purified water; gelatin; carmoisine; patent blue v - temporary relief of cold and flu symptoms, including headaches, body aches and pains, blocked nose, runny nose and dry irritated coughs. reduces fever.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

procter & gamble australia pty ltd - dextromethorphan hydrobromide monohydrate, quantity: 1.333 mg/ml - oral liquid - excipient ingredients: sodium citrate dihydrate; propylene glycol; citric acid; carmellose sodium; polyethylene oxide; saccharin sodium; purified water; menthoxypropanediol; sodium benzoate; peg-40 stearate; ethanol; sucrose; flavour - cough suppressant - provides temporary relief of dry cough associated with colds and influenza.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

reckitt benckiser pty ltd - dextromethorphan hydrobromide monohydrate -